Standard Biotools LAB
NASDAQ LAB
$0.71 +0.06 (+9.23%)
At close: Nov 13, 2026 · 4:00 PM EST

Standard Biotools (LAB) EBITDA Margin (2010 - 2026)

Updated

Standard Biotools (LAB) posted EBITDA Margin of -95.77% for Q3 2026, up 64.91 percentage points from -160.68% a year earlier and up 24.18 percentage points from the prior quarter.

Analysis

Standard Biotools (LAB) EBITDA Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, EBITDA Margin at Standard Biotools was -91.34%, up 22.25 percentage points year-over-year; for FY2025, it came in at -116.34%, up 5.22 percentage points from FY2024.

  • Annual EBITDA Margin shows a five-year change of -91.32 percentage points (FY2020 to FY2025).
  • In prior years, Standard Biotools' EBITDA Margin was -121.55% in FY2024 (-64.52 pp), -57.03% in FY2023 (+45.42 pp), -102.45% in FY2022 (-63.19 pp) and -39.26% in FY2021 (-14.24 pp).
  • Quarterly EBITDA Margin has run from a low of -199.58% in Q2 2022 to a high of -34.96% in Q4 2021 over five years.
  • On a year-over-year basis, EBITDA Margin increased in four of the last eight quarters, with an average year-over-year change of +4.58 percentage points.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2023, with a gain of 150.37 percentage points; the weakest was Q2 2022, with a drop of 170.00 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -119.95% (Q2 2026), -52.44% (Q1 2026) and -98.14% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 25.44%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 20.09%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 30.00%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 25.90%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 25.55%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 23.14%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 20.05%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 9.79%
10 Standard Biotools 280.22 Mn -1.30 Bn 10.83 Mn -95.77%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -95.77%
Jun 30, 2026 -119.95%
Mar 31, 2026 -52.44%
Dec 31, 2025 -98.14%
Sep 30, 2025 -160.68%
Jun 30, 2025 -99.73%
Mar 31, 2025 -112.74%
Dec 31, 2024 -89.31%
Sep 30, 2024 -103.42%
Jun 30, 2024 -117.40%
Mar 31, 2024 -120.75%
Dec 31, 2023 -61.40%
Sep 30, 2023 -67.01%
Jun 30, 2023 -49.22%
Mar 31, 2023 -50.67%
Dec 31, 2022 -63.99%
Sep 30, 2022 -98.34%
Jun 30, 2022 -183.82%
Mar 31, 2022 -87.99%
Dec 31, 2021 -34.96%
API Access

Standard Biotools EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LAB&period=max&api_key=YOUR_API_KEY